A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
Author(s) -
Julian Kaboggoza,
Xinxhu Wang,
Megan Neary,
Pedro Ayuso,
Christine SekaggyaWiltshire,
Shadia Nakalema,
Andrew Owen,
Myra O. McClure,
Mohammed Lamorde,
Marta Boffito
Publication year - 2019
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofz035
Subject(s) - medicine , isoniazid , efavirenz , rifampicin , tuberculosis , pharmacology , rifapentine , mycobacterium tuberculosis , virology , human immunodeficiency virus (hiv) , viral load , pathology , antiretroviral therapy , latent tuberculosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom